Does vitamin D deficiency contribute to erectile dysfunction?

Dermato-Endocrinology

Volumn 4, Issue 2, 2012, Pages 128-136

  Sorenson, Marc B ^a   Grant, William B ^b  

^a Sunlight Institute   (United States)

^b Sunlight Nutrition and Health Research Center (SUNARC)   (United States)

Author keywords

Calcification; Diabetes; Erectile dysfunction; Hypertension; Inflammation; Nitric oxide; Peripheral arterial disease; Vascular diseases; Vasodilation; Vitamin D

Indexed keywords

ANGIOTENSIN; CALCITRIOL; CALCIUM; COLECALCIFEROL; MATRIX METALLOPROTEINASE 14; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RENIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VITAMIN D;

ALZHEIMER DISEASE; ARTERY CALCIFICATION; ASTHMA; ATHEROSCLEROSIS; ATOPIC DERMATITIS; CARDIOVASCULAR RISK; CELL FUNCTION; CHRONIC KIDNEY DISEASE; DEPRESSION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; FALLING; FRAGILITY FRACTURE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC SYNDROME X; MULTIPLE SCLEROSIS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PARKINSON DISEASE; PERIODONTAL DISEASE; REVIEW; SMOKING; STROKE; SUN EXPOSURE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE ACTIVATION; ULTRAVIOLET B RADIATION; VASCULAR ENDOTHELIUM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84865185523     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.20361     Document Type: Review

References (147)

1. Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, Zittermann A, et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2011; 75:575-84; PMID:21682758; http://dx.doi.org/10.1111/j.1365-2265.2011.04147.x
2. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010; 9:709-15; PMID: 20601202; http://dx.doi.org/10.1016/j.autrev.2010.06.009
3. Ginde AA, Liu MC, Camargo CA, Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626-32; PMID:19307527; http://dx.doi.org/10.1001/archinternmed.2008.604
4. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84:50-6; PMID:10444124; http://dx.doi.org/10.1046/j.1464-410x.1999. 00142.x
5. Araujo AB, Hall SA, Ganz P, Chiu GR, Rosen RC, Kupelian V, et al. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? J Am Coll Cardiol 2010; 55:350-6; PMID:20117441; http://dx.doi.org/10.1016/j.jacc.2009.08.058
6. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000; 12(Suppl 4):S6-11; PMID:11035380; http://dx.doi.org/10.1038/sj.ijir.3900567
7. Schouten BW, Bohnen AM, Dohle GR, Groeneveld FP, Willemsen S, Thomas S, et al. Risk factors for deterioration of erectile function: the Krimpen study. Int J Androl 2009; 32:166-75; PMID:18067566; http://dx.doi.org/10.1111/j.1365- 2605.2007.00830.x
8. Valles Antuña C, Fernández Gómez JM, Escaf S, Fernández-González F. Neurogenic etiology in patients with erectile dysfunction. Arch Esp Urol 2008; 61:403-11; PMID:18581678
9. Kloner RA. Erectile dysfunction and cardiovascular risk factors. Urol Clin North Am 2005; 32:397-402, v; PMID:16291032; http://dx.doi.org/10.1016/j. ucl.2005.08.005
10. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ, Urologic Diseases in America Project. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006; 166:207-12; PMID:16432090; http://dx.doi.org/10.1001/archinte.166.2.207
11. Billups KL, Bank AJ, Padma-Nathan H, Katz SD, Williams RA. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res 2008; 20:236-42; PMID:18200018; http://dx.doi.org/10.1038/sj.ijir.3901634
12. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89:251-3; PMID:12591819; http://dx.doi.org/10.1136/heart.89.3.251
13. Meldrum DR, Gambone JC, Morris MA, Meldrum DA, Esposito K, Ignarro LJ. The link between erectile and cardiovascular health: the canary in the coal mine. Am J Cardiol 2011; 108:599-606; PMID:21624550; http://dx.doi.org/10.1016/ j.amjcard.2011.03.093
14. Bird IM. Endothelial nitric oxide synthase activation and nitric oxide function: new light through old windows. J Endocrinol 2011; 210:239-41; PMID: 21824899; http://dx.doi.org/10.1530/JOE-11-0216
15. Web MD Erectile Dysfunction Health Center. Erectile dysfunction: how an erection occurs. http://www.webmd.com/erectile-dysfunction/guide/how-an- erection-occurs. Accessed October 29, 2011.
16. Ghiadoni L, Taddei S, Virdis A. Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol 2012; 10:42-60; PMID:22112351; http://dx.doi.org/10.2174/157016112798829823
17. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 2007; 52:1590-600; PMID:17707576; http://dx.doi.org/10.1016/j. eururo.2007.08.004
18. Nehra A. Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions. Mayo Clin Proc 2009; 84:139-48; PMID:19181648; http://dx.doi.org/10.4065/84.2.139
19. Menezes A, Artham S, Lavie CJ, Milani RV, O'Keefe J. Erectile dysfunction and cardiovascular disease. Postgrad Med 2011; 123:7-16; PMID:21566411
20. Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke. Circulation 2006; 114:63-75; PMID:16818829; http://dx.doi.org/10.1161/ CIRCULATIONAHA.105.593418
21. Stöppler MC, Lee D, Kulic D, Peripheral MD. Vascular Disease. Medicine Net.com. http://www.medicinenet.com/peripheral-vascular-disease/ article.htm. Accessed January 5, 2012.
22. Erectile dysfunction. Mayo Clinic Online. http://www.mayoclinic.com/ health/erectile-dysfunction/HB00074 Accessed October 25, 2011.
23. Gazzaruso C, Coppola A, Montalcini T, Valenti C, Garzaniti A, Pelissero G, et al. Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine 2011; 40:273-9; PMID: 21861245; http://dx.doi.org/10.1007/ s12020-011-9523-9
24. Salem S, Abdi S, Mehrsai A, Saboury B, Saraji A, Shokohideh V, et al. Erectile dysfunction severity as a risk predictor for coronary artery disease. J Sex Med 2009; 6:3425-32; PMID:19796020; http://dx.doi.org/10.1111/j.1743-6109. 2009.01515.x
25. Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R. Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med 2005; 2:40-50, discussion 50-2; PMID:16422903; http://dx.doi.org/10.1111/j.1743-6109.2005.20104-1.x
26. Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract 2010; 64:848-57; PMID: 20584218; http://dx.doi.org/10.1111/j.1742-1241.2010.02410.x
27. Polonsky TS, Taillon LA, Sheth H, Min JK, Archer SL, Ward RP. The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis 2009; 207:440-4; PMID:19501825; http://dx.doi.org/10.1016/j.atherosclerosis.2009.05. 005
28. Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P, et al. ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation 2010; 121:1439-46; PMID:20231536; http://dx.doi.org/10.1161/ CIRCULATIONAHA.109.864199
29. Los Angeles Times Online. March 16, 2010. http://articles.latimes.com/ 2010/mar/16/science/la-sci-ed-heart16-2010 Mar16 Accessed October 26, 2011.
30. Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol 2004; 43:1405-11; PMID:15093875; http://dx.doi.org/10.1016/j.jacc. 2003.11.041
31. Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2011; 171:1797-803; PMID:21911624; http://dx.doi.org/10.1001/archinternmed.2011.440
32. Makariou SE, Liberopoulos EN, Agouridis AP, Challa A, Elisaf M. Effect of Rosuvastatin Monotherapy and in Combination With Fenofibrate or Omega-3 Fatty Acids on Serum Vitamin D Levels. J Cardiovasc Pharmacol Ther 2012; In press; PMID:22431864; http://dx.doi.org/10.1177/1074248412439470
33. Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 2011; 58:186-92; PMID: 21718915; http://dx.doi.org/10.1016/j.jacc.2011.02.051
34. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011; 57:63-9; PMID:21115878; http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.160929
35. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2012; 109:359-63; PMID:22071212; http://dx.doi.org/10.1016/j.amjcard. 2011.09.020
36. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxy-vitamin D and risk of myocardial infarction in men. Ann Intern Med 2008; 168:1174-80; http://dx.doi.org/10.1001/archinte.168.11.1174
37. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96:1755-60; PMID:9323058
38. Beadenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. Am J Roentgenol Radium Ther Nucl Med 1964; 92:865-71; PMID: 14215099
39. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827-32; PMID:2407762; http://dx.doi.org/10.1016/0735-1097(90)90282-T
40. Feldman C, Vitola D, Schiavo N. Detection of coronary artery disease based on the calcification index obtained by helical computed tomography. Arq Bras Cardiol 2000; 75:471-80; PMID:11175472; http://dx.doi.org/10.1590/S0066- 782X2000001200002
41. Kitamura A, Kobayashi T, Ueda K, Okada T, Awata N, Sato S, et al. Evaluation of coronary artery calcification by multi-detector row computed tomography for the detection of coronary artery stenosis in Japanese patients. J Epidemiol 2005; 15:187-93; PMID:16195639; http://dx.doi.org/10.2188/jea.15.187
42. Santos RD, Rumberger JA, Budoff MJ, Shaw LJ, Orakzai SH, Berman D, et al. Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortality. Atherosclerosis 2010; 209:131-5.
43. Jacobs PC, Prokop M, van der Graaf Y, Gondrie MJ, Janssen KJ, de Koning HJ, et al. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. Atherosclerosis 2010; 209:455-62; PMID:19875116; http://dx.doi.org/10.1016/j. atherosclerosis.2009.09.031
44. Lee JH, Ngengwe R, Jones P, Tang F, O'Keefe JH. Erectile dysfunction as a coronary artery disease risk equivalent. J Nucl Cardiol 2008; 15:800-3; PMID: 18984455
45. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol 2007; 18:41-6; PMID:17218831; http://dx.doi.org/10.1097/MOL.0b013e328011c6fc
46. National Diabetes Fact Sheet. 2007. Available at http://www.cdc.gov/ diabetes/pubs/pdf/ndfs-2007.pdf. Accessed November 25, 2011.
47. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 2007; 167:1145-51; PMID:17563022; http://dx.doi.org/10.1001/archinte.167.11.1145
48. Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D'Agostino RB, Sr. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 2006; 113:2914-8; PMID:16785337; http://dx.doi.org/10.1161/CIRCULATIONAHA.106.613828
49. Fang J, Alderman MH. Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000. Diabetes 2006; 55: 768-73; PMID:16505241; http://dx.doi.org/10.2337/diabetes.55.03.06.db05-1196
50. Tousoulis D, Kampoli AM, Stefanadis C. Diabetes mellitus and vascular endothelial dysfunction: current perspectives. Curr Vasc Pharmacol 2012; 10:19-32; PMID:22112354; http://dx.doi.org/10.2174/157016112798829797
51. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 2000; 130:963-74; PMID: 10882379; http://dx.doi.org/10.1038/sj.bjp.0703393
52. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27:567-74; PMID:8606266; http://dx.doi.org/10.1016/0735-1097(95)00522-6
53. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287:2570-81; PMID: 12020339; http://dx.doi.org/10.1001/jama.287.19.2570
54. Awad H, Salem A, Gadalla A, El Wafa NA, Mohamed OA. Erectile function in men with diabetes type 2: correlation with glycemic control. Int J Impot Res 2010; 22:36-9; PMID:19759543; http://dx.doi.org/10.1038/ijir.2009.39
55. You RX, McNeil JJ, O'Malley HM, Davis SM, Thrift AG, Donnan GA. Risk factors for stroke due to cerebral infarction in young adults. Stroke 1997; 28:1913-8; PMID:9341695; http://dx.doi.org/10.1161/01.STR.28.10.1913
56. Phé V, Rouprêt M. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies. Diabetes Metab 2012; 38:1-13; PMID:22056307; http://dx.doi.org/10.1016/j.diabet.2011.09.003
57. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007; 120:151-7; PMID:17275456; http://dx.doi.org/10.1016/j.amjmed.2006.06.010
58. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001; 166:569-74, discussion 574-5; PMID:11458070; http://dx.doi.org/10.1016/S0022-5347(05)65986-1
59. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009; 6:1232-47; PMID: 19210706; http://dx.doi.org/10.1111/j.1743-6109.2008. 01168.x
60. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151:54-61; PMID: 8254833
61. Ishii H, Suzuki H, Baba T, Nakamura K, Watanabe T. Seasonal variation of glycemic control in type 2 diabetic patients. Diabetes Care 2001; 24:1503; PMID:11473100; http://dx.doi.org/10.2337/diacare.24.8.1503
62. Colas C, Garabedian M, Fontbonne A, Guillozo H, Slama G, Desplanque N, et al. Insulin secretion and plasma 1,25-(OH)2D after UV-B irradiation in healthy adults. Horm Metab Res 1989; 21:154-5; PMID:2663692; http://dx.doi.org/10.1055/ s-2007-1009178
63. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30:980-6; PMID:17277040; http://dx.doi.org/10.2337/dc06-1994
64. Nazarian S, St Peter JV, Boston RC, Jones SA, Mariash CN. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl Res 2011; 158:276-81; PMID:22005267; http://dx.doi.org/10.1016/ j.trsl.2011.05.002
65. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94:486-94; PMID:21715514; http://dx.doi.org/10.3945/ajcn.111.011684
66. Bowman TS, Sesso HD, Gaziano JM. Effect of age on blood pressure parameters and risk of cardiovascular death in men. Am J Hypertens 2006; 19:47-52; PMID: 16461190; http://dx.doi.org/10.1016/j.amjhyper.2005.06.024
67. Gu D, Kelly TN, Wu X, Chen J, Duan X, Huang JF, et al. Blood pressure and risk of cardiovascular disease in Chinese men and women. Am J Hypertens 2008; 21:265-72; PMID:18188156; http://dx.doi.org/10.1038/ajh.2007.59
68. Sanford School of Medicine, Stanford Stroke Center. Available online at http://strokecenter.stanford.edu/guide/prevention.html. Accessed Nov 30, 2011.
69. Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM. Risk factors. Stroke 1997; 38:1507-17. (Pubitemid 27300695)
70. Manolis A, Doumas M. Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications. J Hypertens 2008; 26:2074-84; PMID: 18854743; http://dx.doi.org/10.1097/HJH.0b013e32830dd0c6
71. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164:1188-91; PMID:10992363; http://dx.doi.org/10.1016/S0022-5347(05)67138-8
72. Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 2004; 64:1196-201; PMID:15596196; http://dx.doi.org/10.1016/j.urology.2004.08. 059
73. Chung SD, Chen YK, Lin HC, Lin HC. Increased risk of stroke among men with erectile dysfunction: a nationwide population-based study. J Sex Med 2011; 8:240-6; PMID:20722781; http://dx.doi.org/10.1111/j.1743-6109.2010.01973.x
74. Sigmund CD. Regulation of renin expression and blood pressure by vitamin D(3). J Clin Invest 2002; 110:155-6; PMID:12122105
75. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89-90:387-92; PMID:15225806; http://dx.doi.org/10.1016/j.jsbmb.2004.03.004
76. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the reninangiotensin system in humans. Hypertension 2010; 55:1283-8; PMID:20351344; http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.148619
77. Ullah MI, Uwaifo GI, Nicholas WC, Koch CA. Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int J Endocrinol 2010; 2010:579640; PMID: 20049157
78. Charach G, Rabinovich PD, Weintraub M. Seasonal changes in blood pressure and frequency of related complications in elderly Israeli patients with essential hypertension. Gerontology 2004; 50:315-21; PMID: 15331861; http://dx.doi.org/10.1159/000079130
79. Polat M, Akil I, Yuksel H, Coskun S, Yilmaz D, Erguder I, et al. The effect of seasonal changes on blood pressure and urine specific gravity in children living in Mediterranean climate. Med Sci Monit 2006; 12:CR186-90; PMID:16572065
80. Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet 1998; 352:709-10; PMID:9728997; http://dx.doi.org/10.1016/S0140-6736(05)60827-6
81. Opländer C, Volkmar CM, Paunel-Görgülü A, van Faassen EE, Heiss C, Kelm M, et al. Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ Res 2009; 105:1031-40; PMID:19797169; http://dx.doi.org/10. 1161/CIRCRESAHA.109.207019
82. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49:1063-9; PMID:17372031; http://dx.doi.org/10. 1161/HYPERTENSIONAHA.107.087288
83. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106:963-8; PMID:20854958; http://dx.doi.org/10.1016/j.amjcard.2010.05.027
84. Trepels T, Zeiher AM, Fichtlscherer S. The endothelium and inflammation. Endothelium 2006; 13:423-9; PMID:17169774; http://dx.doi.org/10.1080/ 10623320601061862
85. Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J 2011; 75:2739-48; PMID:22067929; http://dx.doi.org/10.1253/ circj.CJ-11-1184
86. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ J 2010; 74:213-20; PMID:20065609; http://dx.doi.org/10.1253/circj.CJ-09-0706
87. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006; 83:456S-60S; PMID:16470012
88. Cybulsky MI, Gimbrone MA, Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251:788-91; PMID:1990440; http://dx.doi.org/10.1126/science.1990440
89. Li H, Cybulsky MI, Gimbrone MA, Jr., Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 1993; 143:1551-9; PMID:7504883
90. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998; 2:275-81; PMID:9734366; http://dx.doi.org/10.1016/S1097-2765(00)80139-2
91. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394:894-7; PMID:9732872; http://dx.doi.org/10.1038/29788
92. Chiurlia E, D'Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol 2005; 46:1503-6; PMID: 16226175; http://dx.doi.org/10.1016/j.jacc.2005.06.068
93. Zambon JP, Mendonça RR, Wroclawski ML, Karam Junior A, Santos RD, Carvalho JA, et al. Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case-control study. Sao Paulo Med J 2010; 128:137-40; PMID:20963365; http://dx.doi.org/10.1590/S1516-31802010000300006
94. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106:913-9; PMID:12186793; http://dx.doi.org/10.1161/01.CIR.0000029802.88087.5E
95. Bocchio M, Desideri G, Scarpelli P, Necozione S, Properzi G, Spartera C, et al. Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol 2004; 171:1601-4; PMID:15017230; http://dx.doi.org/10.1097/01.ju.0000116325.06572.85
96. Carneiro FS, Webb RC, Tostes RC. Emerging role for TNF-α in erectile dysfunction. J Sex Med 2010; 7:3823-34; PMID:20345734; http://dx.doi.org/10.1111/j.1743-6109.2010.01762.x
97. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine 2010; 77:552-7; PMID: 21067953; http://dx.doi.org/10.1016/j.jbspin.2010.09.018
98. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005; 94:483-92; PMID: 16197570; http://dx.doi.org/10.1079/BJN20051544
99. Müller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992; 4:506-12; PMID:1337987; http://dx.doi.org/10.1016/1043-4666(92)90012-G
100. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83:731-2; PMID:16600920
101. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001; 145:351-7; PMID:11517017; http://dx.doi.org/10.1530/eje.0.1450351
102. Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond) 2008; 5:10; PMID: 18652680; http://dx.doi.org/ 10.1186/1476-9255-5-10
103. Martinesi M, Bruni S, Stio M, Treves C. 1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells. Cell Biol Int 2006; 30:365-75; PMID: 16549374; http://dx.doi.org/10. 1016/j.cellbi.2006.01.004
104. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120:687-98; PMID:19667238; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.856070
105. Riek AE, Oh J, Bernal-Mizrachi C. Vitamin D regulates macrophage cholesterol metabolism in diabetes. J Steroid Biochem Mol Biol 2010; 121:430-3; PMID:20338238; http://dx.doi.org/10.1016/j.jsbmb.2010.03.018
106. Yiu YF, Chan YH, Yiu KH, Siu CW, Li SW, Wong LY, et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 2011; 96:E830-5; PMID:21325459; http://dx.doi.org/10.1210/jc. 2010-2212
107. Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66:5314-21; PMID: 9784538
108. Willems HM, van den Heuvel EG, Carmeliet G, Schaafsma A, Klein-Nulend J, Bakker AD. VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts. Steroids 2012; 77:126-31; PMID:22093484; http://dx.doi.org/10.1016/j.steroids.2011.10.015
109. Molinari C, Uberti F, Grossini E, Vacca G, Carda S, Invernizzi M, et al. 1a,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 2011; 27:661-8; PMID: 21691084; http://dx.doi.org/10.1159/000330075
110. Tare M, Emmett SJ, Coleman HA, Skordilis C, Eyles DW, Morley R, et al. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol 2011; 589:4777-86; PMID:21807617; http://dx.doi.org/10.1113/jphysiol.2011.214726
111. Chua GT, Chan YC, Cheng SW. Vitamin D status and peripheral arterial disease: evidence so far. Vasc Health Risk Manag 2011; 7:671-5; PMID:22140318
112. Stach K, Kälsch AI, Nguyen XD, Elmas E, Kralev S, Lang S, et al. 1α,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells. Cardiology 2011; 118:107-15; PMID:21546774; http://dx.doi.org/10.1159/000327547
113. Nathan Seppa, Science News December 17, 2011, reporting on AHA Scientific sessions: Arnson Y, Amital H, Mosseri M. Short-term vitamin D inhibits the increase in inflammatory cytokine and adhesion molecule levels in patients after a coronary event. Abstract # 11373. American Heart Association Scientific Sessions, November 12, 2011, Orlando, Fla.
114. Chen S, Law CS, Gardner DG. Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of cdk2 activity. J Steroid Biochem Mol Biol 2010; 122:326-32; PMID:20813185; http://dx.doi.org/10.1016/j.jsbmb.2010.08.007
115. Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, et al. 25-hydroxyvitamin D3-1α-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005; 111:1666-71; PMID:15795327; http://dx.doi.org/10.1161/01.CIR. 0000160353.27927.70
116. Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang JH. Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey. J Sex Med 2007; 4:57-65; PMID:17081223; http://dx.doi.org/10.1111/j. 1743-6109.2006.00340.x
117. Kupelian V, Link CL, Rosen RC, McKinlay JB. Socioeconomic status, not race/ethnicity, contributes to variation in the prevalence of erectile dysfunction: results from the Boston Area Community Health (BACH) Survey. J Sex Med 2008; 5:1325-33; PMID: 18410305; http://dx.doi.org/10.1111/j.1743-6109.2008. 00822.x
118. Zeiss AM, Davies HD, Wood M, Tinklenberg JR. The incidence and correlates of erectile problems in patients with Alzheimer's disease. Arch Sex Behav 1990; 19:325-31; PMID:2400296; http://dx.doi.org/10.1007/BF01541927
119. Grant WB. Does vitamin D reduce the risk of dementia? J Alzheimers Dis 2009; 17:151-9; PMID: 19494440
120. Chou KT, Huang CC, Chen YM, Perng DW, Chao HS, Chan WL, et al. Asthma and risk of erectile dysfunction-a nationwide population-based study. J Sex Med 2011; 8:1754-60; PMID:21426497; http://dx.doi.org/10.1111/j.1743-6109.2011. 02242.x
121. Bozzetto S, Carraro S, Giordano G, Boner A, Baraldi E. Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy 2012; 67:10-7; PMID: 21933195; http://dx.doi.org/10.1111/j.1398-9995.2011.02711.x
122. Malekmakan L, Shakeri S, Haghpanah S, Pakfetrat M, Sarvestani AS, Malekmakan A. Epidemiology of erectile dysfunction in hemodialysis patients using IIEF questionnaire. Saudi J Kidney Dis Transpl 2011; 22:232-6; PMID:21422619
123. Kim HS, Chung W, Kim S. Vitamin d, and kidney disease. Electrolyte Blood Press 2011; 9:1-6; PMID: 21998600; http://dx.doi.org/10.5049/EBP.2011.9.1.1
124. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011; 58:374-82; PMID:21636193
125. Perelman MA. Erectile dysfunction and depression: screening and treatment. Urol Clin North Am 2011; 38:125-39; PMID:21621079; http://dx.doi.org/10.1016/j.ucl.2011.03.004
126. Hoang MT, Defina LF, Willis BL, Leonard DS, Weiner MF, Brown ES. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc 2011; 86:1050-5; PMID:22033249; http://dx.doi.org/10.4065/mcp.2011.0208
127. Frost M, Abrahamsen B, Masud T, Brixen K. Risk factors for fracture in elderly men: a population-based prospective study. Osteoporos Int 2012; 23:521-31; PMID:21409435; http://dx.doi.org/10.1007/s00198-011-1575-4
128. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293:2257-64; PMID:15886381; http://dx.doi.org/10.1001/jama.293.18.2257
129. Lee RK, Chughtai B, Te AE, Kaplan SA. Sexual function in men with metabolic syndrome. Urol Clin North Am 2012; 39:53-62; PMID:22118345; http://dx.doi.org/10.1016/j.ucl.2011.09.008
130. Al-Daghri NM, Alkharfy KM, Al-Saleh Y, Al-Attas OS, Alokail MS, Al-Othman A, et al. Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism 2011; In press; PMID:22075268; http://dx.doi.org/10.1016/j.metabol.2011.09.017
131. Severson B. Sexual Dysfunction and Multiple Sclerosis. U.S. Dept. of Veterans Affairs, Multiple Sclerosis Center of Excellence. 2010. Available at http://www.va.gov/MS/articles/Sexual-Dysfunction-and-Multiple-Sclerosis.asp. Accessed Dec 27, 2011.
132. Boston Medical Group Online. Multiple Sclerosis and Erectile dysfunction. http://www.multiplesclerosiserectiledysfunction.com/ Accessed December 27, 2011.
133. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62:60-5; PMID:14718698
134. Mirzaei F, Michels KB, Munger K, O'Reilly E, Chitnis T, Forman MR, et al. Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol 2011; 70:30-40; PMID:21786297; http://dx.doi.org/10.1002/ana.22456
135. Chao JK, Hwang TI, Ma MC, Kuo WH, Liu JH, Chen YP, et al. A survey of
136. Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25- hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond) 2012; 36:387-96; PMID:21694701; http://dx.doi.org/10.1038/ijo.2011.119
137. Roumiguié M, Guillotreau J, Castel-Lacanal E, Malavaud B, De Boissezon X, Marque P, et al. [Assessment of sexual function in men with idiopathic Parkinson's disease using the International Index of Erectile Dysfunction (IIEF-15)]. Prog Urol 2011; 21:67-71; PMID:21193148
138. Evatt ML, DeLong MR, Kumari M, Auinger P, McDermott MP, Tangpricha V, Parkinson Study Group DATATOP Investigators. High prevalence of hypovitaminosisD status in patients with early Parkinson disease. Arch Neurol 2011; 68:314-9; PMID:21403017; http://dx.doi.org/10.1001/archneurol.2011.30
139. Zadik Y, Bechor R, Galor S, Justo D, Heruti RJ. Erectile dysfunction might be associated with chronic periodontal disease: two ends of the cardiovascular spectrum. J Sex Med 2009; 6:1111-6; PMID: 19170861; http://dx.doi.org/10.1111/j.1743-6109.2008.01141.x
140. Grant WB, Boucher BJ. Are Hill's criteria for causality satisfied for vitamin D and periodontal disease? Dermatoendocrinol 2010; 2:30-6; PMID:21547146; http://dx.doi.org/10.4161/derm.2.1.12488
141. Chung SD, Keller JJ, Chu TW, Lin HC. Psoriasis and the risk of erectile dysfunction: a population-based case-control study. J Sex Med 2012; 9:130-5; PMID: 22023713; http://dx.doi.org/10.1111/j.1743-6109.2011.02510.x
142. Rácz E, Prens EP, Kurek D, Kant M, de Ridder D, Mourits S, et al. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways. J Invest Dermatol 2011; 131:1547-58; PMID:21412260; http://dx.doi.org/10.1038/jid.2011.53
143. Safarinejad MR. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res 2003; 15:246-52; PMID:12934051; http://dx.doi.org/10.1038/sj.ijir.3901024
144. Brot C, Jorgensen NR, Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 1999; 53:920-6; PMID:10602348; http://dx.doi.org/10.1038/sj.ejcn.1600870
145. Chung SD, Keller JJ, Lin HC. Association of erectile dysfunction with atopic dermatitis: a population-based case-control study. J Sex Med 2012; 9:679-85; PMID: 22240253; http://dx.doi.org/10.1111/j.1743-6109.2011.02587.x
146. Amestejani M, Salehi BS, Vasigh M, Sobhkhiz A, Karami M, Alinia H, et al. Vitamin d supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol 2012; 11:327-30; PMID: 22395583
147. Drugs.com. Viagra Side Effects. http://www.drugs.com/ sfx/viagra-side-effects.html. Accessed Dec. 20, 2011.